Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
August 20, 2002
Report from the 38th IDSA: STDs, HIV and HIV prevention
E J Erbelding
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
August 17, 2002
Highlights from the 13th meeting of the International Society for Sexually Transmitted Diseases Research
E J Erbelding
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
June 28, 2002
Addressing sexual risk behavior in HIV clinical practice
E J Erbelding
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
May 22, 2001
Resistance testing: a primer for clinicians
E J Erbelding
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
May 22, 2001
Metabolic complications of protease inhibitors: what have we learned so far?
E J Erbelding
Genitourinary Medicine
|
December 1, 1996
The clinical utility of viral load monitoring in HIV infection: strengths and limitations
E J Erbelding, T C Quinn
Dermatologic Clinics
|
January 19, 1999
Urethritis treatment
E J Erbelding, T C Quinn
The Biochemical Journal
|
February 15, 1987
The regulation of glutamine and ketone-body metabolism in the small intestine of the long-term (40-day) streptozotocin-diabetic rat
M Watford, E J Erbelding, E M Smith
International Journal of STD & AIDS
|
February 11, 2004
Following-up for HIV test results: what limits return in an STD clinic population?
E J Erbelding, S Chung, J M Zenilman
Sexually Transmitted Infections
|
December 2, 2004
Differences in demographics and risk factors among men attending public v non-public STD clinics in Baltimore, Maryland
C A Porter, D Thompson, E J Erbelding
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
August 20, 2002
Report from the 38th IDSA: STDs, HIV and HIV prevention
E J Erbelding
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
August 17, 2002
Highlights from the 13th meeting of the International Society for Sexually Transmitted Diseases Research
E J Erbelding
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
June 28, 2002
Addressing sexual risk behavior in HIV clinical practice
E J Erbelding
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
May 22, 2001
Resistance testing: a primer for clinicians
E J Erbelding
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
May 22, 2001
Metabolic complications of protease inhibitors: what have we learned so far?
E J Erbelding
Genitourinary Medicine
|
December 1, 1996
The clinical utility of viral load monitoring in HIV infection: strengths and limitations
E J Erbelding, T C Quinn
Dermatologic Clinics
|
January 19, 1999
Urethritis treatment
E J Erbelding, T C Quinn
The Biochemical Journal
|
February 15, 1987
The regulation of glutamine and ketone-body metabolism in the small intestine of the long-term (40-day) streptozotocin-diabetic rat
M Watford, E J Erbelding, E M Smith
International Journal of STD & AIDS
|
February 11, 2004
Following-up for HIV test results: what limits return in an STD clinic population?
E J Erbelding, S Chung, J M Zenilman
Sexually Transmitted Infections
|
December 2, 2004
Differences in demographics and risk factors among men attending public v non-public STD clinics in Baltimore, Maryland
C A Porter, D Thompson, E J Erbelding
Page
of 3